Ranran Chai
Shanghai, 200011, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
SNX10 Is Involved in Ovarian Cancer Cell Metastasis by Repolarizing Tumor-Associated Macrophages Through mTOR1/Lysosomes Pathway.
Journal: Biomedicines
Published: March 11, 2025
Therapeutic management of PI3Kα inhibitor-induced hyperglycemia with a novel glucokinase activator: Advancing the Frontier of PI3Kα inhibitor therapy.
Journal: Molecular metabolism
Published: January 21, 2025
mTOR Inhibitor Everolimus Modulates Tumor Growth in Small-Cell Carcinoma of the Ovary, Hypercalcemic Type and Augments the Drug Sensitivity of Cancer Cells to Cisplatin.
Journal: Biomedicines
Published: November 13, 2024
Targeting on the PI3K/mTOR: a potential treatment strategy for clear cell ovarian carcinoma.
Journal: Cancer chemotherapy and pharmacology
Published: October 09, 2024
A novel methylation-detection panel for HPV associated high-grade squamous intraepithelial lesion and cervical cancer screening.
Journal: Scientific reports
Published: July 01, 2024
Single-cell RNA sequencing reveals the intra-tumoral heterogeneity and immune microenvironment of small cell carcinoma of the ovary, hypercalcemic type.
Journal: Journal of ovarian research
Published: April 15, 2024
Human Fallopian Tube-Derived Organoids with TP53 and RAD51D Mutations Recapitulate an Early Stage High-Grade Serous Ovarian Cancer Phenotype In Vitro.
Journal: International journal of molecular sciences
Published: November 19, 2023
Chronic Stress Blocks the Endometriosis Immune Response by Metabolic Reprogramming.
Journal: International journal of molecular sciences
Published: October 10, 2023
RAD51D Secondary Mutation-Mediated Resistance to PARP-Inhibitor-Based Therapy in HGSOC.
Journal: International journal of molecular sciences
Published: July 31, 2023
Showing 1-9 of 9
Last Updated: 09/26/2026